Trial · NCT02357901
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Run-In Period (Days -14 to Day -1) | STARTED | Run-In Period | 665 | |
| Run-In Period (Days -14 to Day -1) | STARTED | RBP-6000 300mg/100mg | 0 | |
| Run-In Period (Days -14 to Day -1) | STARTED | RBP-6000 300mg/300mg | 0 | |
| Run-In Period (Days -14 to Day -1) | STARTED | Combined Placebo | 0 | |
| Run-In Period (Days -14 to Day -1) | COMPLETED | Run-In Period | 504 | |
| Run-In Period (Days -14 to Day -1) | COMPLETED | RBP-6000 300mg/100mg | 0 | |
| Run-In Period (Days -14 to Day -1) | COMPLETED | RBP-6000 300mg/300mg | 0 | |
| Run-In Period (Days -14 to Day -1) | COMPLETED | Combined Placebo | 0 | |
| Run-In Period (Days -14 to Day -1) | NOT COMPLETED | Run-In Period | 161 | |
| Run-In Period (Days -14 to Day -1) | NOT COMPLETED | RBP-6000 300mg/100mg | 0 | |
| Run-In Period (Days -14 to Day -1) | NOT COMPLETED | RBP-6000 300mg/300mg | 0 | |
| Run-In Period (Days -14 to Day -1) | NOT COMPLETED | Combined Placebo | 0 | |
| Treatment Period (Day 1 to Week 24) | STARTED | Run-In Period | 0 | |
| Treatment Period (Day 1 to Week 24) | STARTED | RBP-6000 300mg/100mg | 203 | |
| Treatment Period (Day 1 to Week 24) | STARTED | RBP-6000 300mg/300mg | 201 | |
| Treatment Period (Day 1 to Week 24) | STARTED | Combined Placebo | 100 | |
| Treatment Period (Day 1 to Week 24) | Safety Analysis Set | Run-In Period | 0 | |
| Treatment Period (Day 1 to Week 24) | Safety Analysis Set | RBP-6000 300mg/100mg | 203 | |
| Treatment Period (Day 1 to Week 24) | Safety Analysis Set | RBP-6000 300mg/300mg | 201 | |
| Treatment Period (Day 1 to Week 24) | Safety Analysis Set | Combined Placebo | 100 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02357901/flow